Page last updated: 2024-11-05

trimethoprim and Benign Neoplasms, Brain

trimethoprim has been researched along with Benign Neoplasms, Brain in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuyper, LF1
Baccanari, DP1
Jones, ML1
Hunter, RN1
Tansik, RL1
Joyner, SS1
Boytos, CM1
Rudolph, SK1
Knick, V1
Wilson, HR1
Caddell, JM1
Friedman, HS1
Comley, JC1
Stables, JN1
Khan, SH1
Sanche, SE1
Robinson, CA1
Pirouzmand, F1

Other Studies

2 other studies available for trimethoprim and Benign Neoplasms, Brain

ArticleYear
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
    Journal of medicinal chemistry, 1996, Feb-16, Volume: 39, Issue:4

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B

1996
N. paucivorans infection presenting as a brain abscess.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:4

    Topics: Anti-Bacterial Agents; Brain Abscess; Brain Neoplasms; Diagnosis, Differential; Humans; Hypertension

2006